By Kalpna Mistry, Staff Networks Coordinator, Equality, Diversity and Inclusion Centre at Imperial College London
In the UK the law protects the rights of disabled people, for instance the Disability Discrimination Act 1995, which gave way to the Equality Act 2010 describes disability as a protected characteristic. It places the responsibility on service providers and employers to provide a discrimination-free service or make reasonable adjustments in the workplace. So, where 30 years ago if a wheelchair user could not access the cinema due to steps leading to the entrance or there being no wheelchair access in the screening room, the cinema had no obligation to do anything about it.
The diffusion or spread of innovations over time through a specific population or social system is important to unlock the potential benefits of an innovation. There has been much study of how to encourage the uptake of innovations so that they become part of everyday practice and benefit many, rather than a few. In this research, we explore this from the demand side. This report, ‘Global Diffusion of Healthcare Innovation: Making the connections’, which is to be discussed this morning at the World Innovation Summit for Health (WISH) looks at how frontline health workers (FHWs) and leaders find solutions to their everyday challenges, and which sources are the most influential.
Much of the global burden of disease arises from unhealthy behaviors, which people struggle to change even if they have the awareness, intention and ability to do so.
The new report ‘Applying behavioral insights: simple ways to improve health outcomes’ will be discussed at today’s World Innovation Summit for Health (WISH).
The Behavioral Insights Forum will present groundbreaking, evidence-based research showing how citizens’ health can be improved through a better understanding and application of the latest research. Led by a UK government-owned social purpose company, The Behavioral Insights Team, this research studies the factors that influence human behavior thereby producing evidence that can prove vital to improving the health of populations.
By Dr Enrique Castro Sanchez and Dr Bryony Dean Franklin, Centre for Patient Safety and Translational Research (PSTRC), Imperial College London
In the last few months we have seen increased attention and alliances around the world to develop interventions to address the challenge presented by drug-resistant infections. For example, a landmark declaration at the United Nations General Assembly on the matter of Antimicrobial Resistance was signed by 193 countries, providing a historic opportunity for experts, governments and citizens to collaborate on a global response to this worldwide threat to patient safety. Only the fourth time in history that a health topic had been at the centre of attention at the UN, the meeting supported commitment of adequate resources to guarantee a much needed sustained and robust response.
By Dr Olga Kostopoulou, Reader in Medical Decision Making and Professor Brendan Delaney, Chair in Medical Informatics and Decision Making at Imperial College London
Combatting antimicrobial resistance (AMR) is high on policy agendas internationally. One of the key means advocated is judicious antibiotic prescribing. Over 80% of all NHS antibiotic prescriptions are issued in primary care, where despite numerous campaigns, mandates and financial incentives, rates have fallen only slightly in the past year. Acute respiratory infections and associated complications, such as pneumonia, are the commonest justification for primary care antibiotic use, despite strong evidence of small to modest symptomatic benefits.
By Sabine Vuik, Policy Fellow and Head of Analytics, Centre for Health Policy, Institute of Global Health Innovation
Big data and advanced data mining methods are becoming a crucial element of everyday life, business and research. The new insights that these methods can provide have allowed many different industries to find new opportunities, products and markets.
The new EPSRC Centre for Mathematics of Precision Healthcare which will launch on Wednesday 23rd November, aims to bring these methods into healthcare.
Precision Healthcare uses big data and mathematics to provide unprecedented insights into individual and population health. The Centre will link up mathematical, computational and medical departments from Imperial, to bridge traditional silos and drive innovation in this area.
By Joshua Symons, Policy Fellow, Big Data & Analytical Unit, Centre for Health Policy
On the 8th and 9th October, I had the opportunity to attend the Open Data Science Conference in London. In addition to the United Kingdom, the ODSC also occurs on both the East and West Coast of the US, as well as Tokyo. The 2-day conference had an array of speakers presenting problems and solutions they have worked on as data scientists. It was an opportunity to meet some of the leaders in the field of data science such as Gael Varoquaux. Gael is a core contributor to the popular Python machine learning resource scikit-learn and he spoke about the new and existing features of this package which help ensure rapid development in data science.
By guest bloggers Sarah Greaves, Katherine MacInnes and Alex Stockham, IN-PART
For the first time in history, antimicrobial resistance was addressed recently by the United Nations (UN). In New York at the 71st General Assembly of the UN, all 193 member states signed up to combat this ever growing problem.
To fight what is said to be one of the biggest threats to 21st Century society, world leaders committed to a global, coordinated and multi-sector plan of action to not only increase the regulation of antimicrobial drug use but also to increase awareness of antimicrobial resistance and promote the development of alternative antimicrobial drugs.
By Alexander Carter, Health Economist, Centre for Health Policy, IGHI
Earlier this month I was fortunate enough to be invited to the ‘2016 Summit on China Hospital Development’, which also provided an opportunity to visit and learn first-hand about the health reforms there. My destination was Hangzhou – considered China’s most beautiful city – which is also where the recent G20 summit was held. Indeed, it is an enchanting place that seems to draw its energy from the Western lake and the surrounding mountains that cocoon the 9 million strong population in a relatively serene, yet commercially vibrant environment – exemplified by Alibaba, the e-commerce giant, which is based there.
We asked our Director, Professor the Lord Ara Darzi, to explain the importance of patient data sharing, a topic we’ll be discussing during our annual Sowerby eHealth Symposium taking place 14th September at the Royal College of Physicians.
Confirmed topics and speakers include:
Pushing the boundaries of sharing patient data in the real world
- Mustafa Suleyman, Co-founder, Google DeepMind
How to make data sharing policy work
- Katie Farrington, Director of Digital and Data, Department of Health
- Dr. Brian Fisher, Director of PAERs Ltd
- Sharmila Nebhrajani, Director of External Affairs at MRC Human Tissue Authority
- Fran Husson, Patient Representative
Developing a citizen science platform for data sharing: Understanding ‘real life’ patient benefits in Dementia
- Hilary Doxford, Vice-Chair of the European Working Group of People with Dementia, Dementia Research Champion
Predictive modelling, Artificial Intelligence, Population Health, Genomics and Wearables: Applications of data sharing
- Chris Laing, Consultant Nephrologist at the Royal Free London NHS Foundation Trust
- Paul Elliot, Chair in Epidemiology and Public Health Medicine Imperial College London
- Irina Bolychevsky, Open data consultant and Director of Shevski Ltd
- Jen Hyatt, Founder, Big White Wall
Registration begins at 8:30AM, with talks from 9AM-1PM.